Here are the DEF 14A proxy statements from Agape ATP Corporation (ATPC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ATPC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATPC filings page.
Agape ATP Corporation filed an amendment to its proxy materials for the upcoming Annual Meeting to clarify how abstentions and broker non-votes are treated and how certain proposals will be approved.
The revised language explains that broker non-votes arise when brokers lack discretionary authority and do not receive instructions, and confirms they are not counted as shares entitled to vote on non-routine matters. It also emphasizes that beneficial owners must give specific instructions if they want their street-name shares voted on non-routine items.
For Proposal 5, which seeks to amend the articles of incorporation to increase authorized common shares from 500,000,000 to 30,000,000,000, a majority of all voting shares must vote “FOR,” and abstentions and broker non-votes will count as “NO” votes. For Proposal 6, approval requires a majority of shares present and entitled to vote, abstentions count as votes against, and the item is considered routine, so broker non-votes are not expected.
Agape ATP Corporation is asking stockholders to approve several major corporate actions at its virtual annual meeting on January 30, 2026. Holders of 50,027,000 common shares as of November 4, 2025 can vote on ratifying Assentsure PAC as auditor, re-electing five directors, and authorizing potential issuances of common stock with an aggregate offering price of up to $300,000,000 under a future Form S-3 shelf. The company is also seeking authority for the board to implement one or more reverse stock splits of up to 1-for-5,000 and to increase authorized common shares from 500,000,000 to 30,000,000,000, which could significantly expand its ability to issue new equity. Another proposal would allow adjournment of the meeting to solicit more proxies if needed.